Literature DB >> 27467133

Polymorphisms in stearoyl coa desaturase and sterol regulatory element binding protein interact with N-3 polyunsaturated fatty acid intake to modify associations with anthropometric variables and metabolic phenotypes in Yup'ik people.

Dominick J Lemas1,2, Yann C Klimentidis3, Stella Aslibekyan4, Howard W Wiener4, Diane M O'Brien1, Scarlett E Hopkins1, Kimber L Stanhope5,6, Peter J Havel5,6, David B Allison7,8,9, Jose R Fernandez8,10, Hemant K Tiwari7, Bert B Boyer1.   

Abstract

SCOPE: n-3 polyunsaturated fatty acid (n-3 PUFA) intake is associated with protection from obesity; however, the mechanisms of protection remain poorly characterized. The stearoyl CoA desaturase (SCD), insulin-sensitive glucose transporter (SLC2A4), and sterol regulatory element binding protein (SREBF1) genes are transcriptionally regulated by n-3 PUFA intake and harbor polymorphisms associated with obesity. The present study investigated how consumption of n-3 PUFA modifies associations between SCD, SLC2A4, and SREBF1 polymorphisms and anthropometric variables and metabolic phenotypes.
MATERIALS AND METHODS: Anthropometric variables and metabolic phenotypes were measured in a cross-sectional sample of Yup'ik individuals (n = 1135) and 33 polymorphisms were tested for main effects and interactions using linear models that account for familial correlations. n-3 PUFA intake was estimated using red blood cell nitrogen stable isotope ratios. SCD polymorphisms were associated with ApoA1 concentration and n-3 PUFA interactions with SCD polymorphisms were associated with reduced fasting cholesterol levels and waist-to-hip ratio. SLC2A4 polymorphisms were associated with hip circumference, high-density lipoprotein and ApoA1 concentrations. SREBF1 polymorphisms were associated with low-density lipoprotein and HOMA-IR and n-3 PUFA interactions were associated with reduced fasting insulin and HOMA-IR levels.
CONCLUSION: The results suggest that an individual's genotype may interact with dietary n-3 PUFAs in ways that are associated with protection from obesity-related diseases in Yup'ik people.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alaska Native; BMI; Gene-by-environment interactions; n-3 PUFA

Mesh:

Substances:

Year:  2016        PMID: 27467133      PMCID: PMC5148654          DOI: 10.1002/mnfr.201600170

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  58 in total

Review 1.  Healthy obesity.

Authors:  Rachel P Wildman
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-07       Impact factor: 4.294

2.  CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people.

Authors:  Yann C Klimentidis; Dominick J Lemas; Howard H Wiener; Diane M O'Brien; Peter J Havel; Kimber L Stanhope; Scarlett E Hopkins; Hemant K Tiwari; Bert B Boyer
Journal:  J Diabetes       Date:  2013-10-29       Impact factor: 4.006

3.  Interacting genetic loci on chromosomes 20 and 10 influence extreme human obesity.

Authors:  Chuanhui Dong; Shuang Wang; Wei-Dong Li; Ding Li; Hongyu Zhao; R Arlen Price
Journal:  Am J Hum Genet       Date:  2002-12-11       Impact factor: 11.025

4.  Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay.

Authors:  J Xu; M Teran-Garcia; J H Park; M T Nakamura; S D Clarke
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

5.  Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity.

Authors:  James M Ntambi; Makoto Miyazaki; Jonathan P Stoehr; Hong Lan; Christina M Kendziorski; Brian S Yandell; Yang Song; Paul Cohen; Jeffrey M Friedman; Alan D Attie
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

6.  The Center for Alaska Native Health Research Study: a community-based participatory research study of obesity and chronic disease-related protective and risk factors.

Authors:  Gerald V Mohatt; Rosemarie Plaetke; Joseph Klejka; Bret Luick; Cécile Lardon; Andrea Bersamin; Scarlett Hopkins; Michelle Dondanville; Johanna Herron; Bert Boyer
Journal:  Int J Circumpolar Health       Date:  2007-02       Impact factor: 1.228

7.  SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.

Authors:  H K Berthold; R Laaksonen; T Lehtimäki; H Gylling; W Krone; I Gouni-Berthold
Journal:  Exp Clin Endocrinol Diabetes       Date:  2007-12-10       Impact factor: 2.949

8.  Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.

Authors:  Dick C Chan; Gerald F Watts; Trevor A Mori; P Hugh R Barrett; Trevor G Redgrave; Lawrence J Beilin
Journal:  Am J Clin Nutr       Date:  2003-02       Impact factor: 7.045

9.  Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity.

Authors:  Eva Warensjö; Erik Ingelsson; Per Lundmark; Lars Lannfelt; Ann-Christine Syvänen; Bengt Vessby; Ulf Risérus
Journal:  Obesity (Silver Spring)       Date:  2007-07       Impact factor: 5.002

10.  SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation.

Authors:  Annie Bouchard-Mercier; Iwona Rudkowska; Simone Lemieux; Patrick Couture; Louis Pérusse; Marie-Claude Vohl
Journal:  Lipids Health Dis       Date:  2014-10-01       Impact factor: 3.876

View more
  2 in total

1.  Alaska Native Traditional Food and Harvesting Activity Patterns over 10 Years of Follow-Up.

Authors:  Diana G Redwood; Gretchen M Day; Julie A Beans; Vanessa Y Hiratsuka; Sarah H Nash; Barbara V Howard; Jason G Umans; Kathryn R Koller
Journal:  Curr Dev Nutr       Date:  2019-10-09

2.  Plasma Lipolysis and Changes in Plasma and Cerebrospinal Fluid Signaling Lipids Reveal Abnormal Lipid Metabolism in Chronic Migraine.

Authors:  Katherine Castor; Jessica Dawlaty; Xianghong Arakaki; Noah Gross; Yohannes W Woldeamanuel; Michael G Harrington; Robert P Cowan; Alfred N Fonteh
Journal:  Front Mol Neurosci       Date:  2021-08-31       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.